McDermott + Bull has successfully placed Scott Durbin as Chief Executive Officer at illumiSonics. In this role, Scott will partner with the Board and leadership team to cultivate the strategic vision, streamline the go-to-market strategy, strengthen their world-class...
McDermott + Bull has successfully placed Michael Zuckerman as Chief Executive Officer at private equity-backed Ensemble Therapy. Michael will work closely with the private equity firm Carroll Capital to enhance the company’s platform, drive scalability, and build...
McDermott + Bull has successfully placed Brian Sill as Chief Financial Officer at Nuance Medical. In this role, Brian will be instrumental in shaping the company’s financial trajectory as its inaugural CFO. He will oversee the development and expansion of the finance,...
McDermott + Bull has successfully placed Joshua (Josh) Woolley as Vice President of Clinical Affairs and Regulatory at Aria CV. Josh will be responsible for launching the company’s early feasibility study and leading ongoing engagements with the FDA to drive product...
McDermott + Bull has successfully placed David O’Toole as Chief Financial Officer at AVITA Medical (NASDAQ: RCEL, ASX: AVH). David will report to and work closely with the CEO, serving as a valued member of the executive leadership team. In this role, he will provide...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
